ATP Detection By Quantitative Mass Spec Imaging (QMSI)

Aliri’s cutting-edge ATP pathway detection using quantitative mass spectrometry imaging (QMSI) provides pharmaceutical companies with a powerful tool to analyze the distribution and localization of key molecules within the tissue microenvironment.

Given the bioanalytical complexities associated with this class of molecules, integrating QMSI into discovery or clinical research offers several advantages. This technology enables researchers to correlate the distribution of ATP, ADP, adenosine, and inosine, visualizing their presence within tissues while also assessing their abundance in the microenvironment. Additionally, QMSI delivers valuable analytical insights without compromising data quality or molecular stability. By leveraging this approach, researchers can streamline workflows, reduce costs, and enhance the efficiency of their bioanalytical processes.